- Home
- AXSM vs KNX Comparison
AXSM vs KNX Comparison
Compare AXSM & KNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- KNX
- Stock Information
- Founded
- AXSM 2012
- KNX 1989
- Country
- AXSM United States
- KNX United States
- Employees
- AXSM N/A
- KNX N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- KNX Trucking Freight/Courier Services
- Sector
- AXSM Health Care
- KNX Industrials
- Exchange
- AXSM Nasdaq
- KNX Nasdaq
- Market Cap
- AXSM 5.9B
- KNX 7.0B
- IPO Year
- AXSM 2015
- KNX 1994
- Fundamental
- Price
- AXSM $145.72
- KNX $41.91
- Analyst Decision
- AXSM Strong Buy
- KNX Strong Buy
- Analyst Count
- AXSM 20
- KNX 17
- Target Price
- AXSM $176.00
- KNX $53.65
- AVG Volume (30 Days)
- AXSM 547.8K
- KNX 3.9M
- Earning Date
- AXSM 11-03-2025
- KNX 10-22-2025
- Dividend Yield
- AXSM N/A
- KNX 1.72%
- EPS Growth
- AXSM N/A
- KNX 280.63
- EPS
- AXSM N/A
- KNX 0.88
- Revenue
- AXSM $561,263,000.00
- KNX $7,477,640,000.00
- Revenue This Year
- AXSM $63.66
- KNX $2.37
- Revenue Next Year
- AXSM $54.46
- KNX $5.58
- P/E Ratio
- AXSM N/A
- KNX $47.69
- Revenue Growth
- AXSM 65.83
- KNX N/A
- 52 Week Low
- AXSM $75.56
- KNX $36.69
- 52 Week High
- AXSM $146.53
- KNX $61.51
- Technical
- Relative Strength Index (RSI)
- AXSM 72.66
- KNX 41.22
- Support Level
- AXSM $136.00
- KNX $43.78
- Resistance Level
- AXSM $144.15
- KNX $45.78
- Average True Range (ATR)
- AXSM 5.82
- KNX 1.66
- MACD
- AXSM 0.32
- KNX -0.38
- Stochastic Oscillator
- AXSM 99.54
- KNX 12.77
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About KNX Knight-Swift Transportation Holdings Inc.
Knight-Swift is the largest full-truckload carrier in the US, with a diversified transportation offering. Pro forma for the US Xpress deal, about 82% of revenue derives from Knight's asset-based trucking business, with full truckload (for-hire dry van, refrigerated, and dedicated contract) making up 69% and less than truckload 13%. Truck brokerage and other asset-light logistics services make up 9% of revenue, with intermodal near 6%. Knight's intermodal operations use the Class I railroads for the underlying movement of its shipping containers and include drayage (regional trucking services to and from inland intermodal ramps/terminals). The remainder of revenue reflects services offered to shippers and third-party truckers, including equipment maintenance and leasing.